Key result
Surgical repair resolves acquired aortic coarctation and paraparesis complicating transcatheter PDA closure.
Why the study?
Acquired coarctation of the aorta is a rare but potentially serious complication of transcatheter patent ductus arteriosus device closure that can present with acute neurological manifestations.
Case Report (n=1)
Acquired aortic coarctation following transcatheter PDA device closure can present with acute neurological symptoms such as paraparesis, highlighting the need for careful device sizing and systematic post-procedural echocardiographic surveillance.
Answers are grounded in this paper and cite their sources.
Acute neurological symptoms may indicate acquired CoA after PDA closure; case report leaves open questions on incidence and surveillance.
Background Transcatheter device closure is an established treatment for patent ductus arteriosus (PDA). Acquired coarctation of the aorta (CoA) is a rare but potentially serious complication of PDA device closure. We report a case of acquired CoA presenting with acute neurological manifestations after PDA device implantation. Case presentation An 18-month-old girl underwent transcatheter closure of a small PDA using a 6/4-mm Amplatzer Duct Occluder II (ADO II). Pre-procedural angiography showed no evidence of CoA or an anterior aortic shelf. Immediately after device deployment, the left ventricular and aortic systolic pressures were both 80 mmHg, with no measurable systolic pressure gradient, and early angiography and echocardiography showed no significant aortic obstruction. Three days after discharge, the patient developed acute bilateral lower-extremity weakness and paraparesis. Brain computed tomography showed no acute intracranial abnormality, and no dedicated spinal imaging was performed. Severe anemia (hemoglobin, 6.5 g/dL) was identified, and lower-extremity weakness improved following blood transfusion. Approximately 3 months after PDA closure, echocardiography demonstrated severe aortic isthmic obstruction with a peak gradient of approximately 45 mmHg and impaired left ventricular systolic function (LVEF, 40–43%). The patient underwent urgent surgical repair, including removal of the ADO II, resection of the narrowed aortic segment, and end-to-end anastomosis. During induction of anesthesia, she developed severe bradycardia requiring approximately 2 min of cardiopulmonary resuscitation. No lower‑extremity paralysis was observed postoperatively; however, abnormal orofacial movements developed, and electroencephalography showed no epileptiform activity. At 6-month follow-up, the neurological manifestations had resolved, while left ventricular systolic function remained mildly depressed. Conclusion Acquired CoA after PDA device closure may present with acute neurological manifestations. This case emphasizes the importance of obtaining a complete history of recent cardiac interventions when evaluating acute neurological symptoms. Careful device selection and sizing, particularly for small PDAs near the aortic isthmus, together with systematic post-procedural surveillance, may facilitate early detection of aortic obstruction and reduce the risk of severe complications.
No takes yet. Share an insight, caveat, or question.
Shahidzade et al. (2026) conducted a case report in Patent ductus arteriosus complicated by acquired coarctation of the aorta (n=1). Transcatheter PDA closure with 6/4-mm Amplatzer Duct Occluder II followed by urgent surgical repair was evaluated on Acquired aortic isthmic obstruction and neurological recovery. Transcatheter PDA closure with a 6/4-mm ADO II was complicated by acquired aortic coarctation and acute paraparesis, resolving by 6 months after surgical repair.
Synapse has enriched 10 related papers. Consider them for comparative context: